India will get 50% of Oxford Coronavirus vaccine doses produced; Serum Institute of India will start Phase 3 trials of vaccine in August: Adar Poonawalla

Adar Poonawalla shared that he is hopeful of that 300 million doses of the vaccine candidate ‘Covidshield’, developed by the Oxford University will be manufactured by December 2020.